White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease

• Үндсэн зохиолчид: Taichiro Muto MD, PhD (Зохиогч), Yu Masuda MD (Зохиогч), Shingo Numoto MD (Зохиогч), Shunsuke Kodama MD (Зохиогч), Kiyoshi Yamakawa MD (Зохиогч), Michihiko Takasu MD (Зохиогч), Tomohito Hayakawa MD (Зохиогч), Kenji Miyata MD (Зохиогч), Ryosuke Miyamoto MD (Зохиогч), Mitsuko Akaihata MD (Зохиогч), Hideyuki Iwayama MD, PhD (Зохиогч), Yoshiro Kitagawa MD, PhD (Зохиогч), Hirokazu Kurahashi MD, PhD (Зохиогч), Yasuto Shimomura MD, PhD (Зохиогч), Toshinori Hori MD, PhD (Зохиогч), Masumi Okuda MD, PhD (Зохиогч), Hiroatsu Agata MD, PhD (Зохиогч), Akihisa Okumura MD, PhD (Зохиогч)
• Формат: Ном
• Хэвлэсэн: SAGE Publishing, 2019-10-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

We explored parameters to predicting the efficacy of intravenous immunoglobulin (IVIG) therapy for patients with Kawasaki disease (KD). We retrospectively analyzed the laboratory data of 77 children with KD treated with IVIG. Data obtained before and within 24 hours after IVIG therapy were compared...